Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
Journal Information
Full Title: Intensive Care Med
Abbreviation: Intensive Care Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Critical Care
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflicts of interestThe authors have disclosed that they do not have any conflicts of interest. Role of the funder/sponsorThe funding sources had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Conflicts of interest The authors have disclosed that they do not have any conflicts of interest."
"Funding Financial support was provided by the Instituto de Salud Carlos III de Madrid (COV20/00110, ISCIII); Fondo Europeo de Desarrollo Regional (FEDER); “Una manera de hacer Europa”; Centro de Investigación Biomedica En Red–Enfermedades Respiratorias (CIBERES); and Donation program “estar preparados” UNESPA, Madrid, Spain. DdGC has received financial support from the Instituto de Salud Carlos III (Miguel Servet 2020: CP20/00041), co-funded by European Social Fund (ESF)/ “Investing in your future”. Adrian Ceccato acknowledges receiving financial support from Instituto de Salud Carlos III (ISCIII; Sara Borrell 2021: CD21/00087)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025